Also (iv), the presence of any red flags (e.g., sudden symptom onset, chronic disease progression, MRI lesion configuration or CSF results suggestive of MS or another inflammatory CNS disease, low or borderline MOG-IgG titers with possible other etiology) should prompt reevaluation of the diagnosis [33, 34, 40]. The gene discussed is MOG; the disease is myeloid sarcoma.